[Asia Economy Reporter Hyunseok Yoo] Microclean, a subsidiary of Brain Contents, has completed all product approval processes with the Ministry of Food and Drug Safety (MFDS) and is scheduled to begin official sales next week.


Microclean announced on the 16th that its self-developed Supia health masks (KF80, KF94) and droplet-blocking masks (KF-AD) have passed conformity tests and completed all product approval processes with the MFDS, and will start official sales next week.


A company representative stated, “Supia health masks and droplet-blocking masks received conformity approvals from FITI Testing & Research Institute and Korea Mask Testing Institute, and completed all product approval processes with the MFDS.” He emphasized, “Supia masks secure stable raw material supply and price competitiveness by sourcing the core MB filter from Toray Advanced Materials, Asia’s number one comprehensive nonwoven fabric company.” He added, “We plan to sell the droplet-blocking masks, which have seen increased demand due to hot weather, by utilizing the abundant infrastructure of our affiliates Swanicoco and Medipron.”


He explained, “The droplet-blocking masks use electrostatic SMS fabric with excellent liquid resistance to block droplets, and are made with a double-layer fabric structure, making them lightweight and comfortable to breathe through. They feature domestically produced ear bands that do not easily break and cause no discomfort even after long hours of wear.”


Currently, Microclean’s Pyeongtaek factory has received all 10 automatic 3D mask machines for manufacturing masks, enabling a production capacity (CAPA) of 240,000 masks per day and 6 million masks per month (40 masks per minute per machine, 10 hours per day, 24,000 masks per day per machine). The company is also planning to obtain GMP certification for quasi-drugs and ISO9001 (2015).


Additionally, on the 6th, dental mask production equipment was delivered, and through equipment commissioning and sample production, Microclean plans to submit an additional product approval application to the MFDS as soon as test results are available from FITI Testing & Research Institute in August. Once approved, production capacity will reach 60,000 dental masks per day and 1.5 million per month.



Moon Jongwook, CEO of Brain Contents, said, “We expect that with full-scale production and sales, this will become a cash cow for the group,” and added, “We will consider expansion depending on market conditions and business progress.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing